Treatment of acute pandysautonomia with intravenous immunoglobulin.
Acute pandysautonomia has been suggested to be an uncommon variant of Guillain-Barre syndrome. Acute pandysautonomia does not seem to have been treated with intravenous immunoglobulin or other therapies proved efficacious in Guillain-Barre syndrome. A patient is reported with severe acute pandysautonomia who responded dramatically to intravenous immunoglobulin. The findings are consistent with a dysimmune pathogenesis for this syndrome and suggest a possible treatment for future cases.
Mericle
R A
RA
Department of Neurology, University of Florida Health Science Center, Gainesville 32610-0236, USA.
Triggs
W J
WJ
D000328:Adult; D001342:Autonomic Nervous System Diseases / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D011129:Polyradiculoneuropathy / Q000175:diagnosis
D016756:Immunoglobulins, Intravenous